In addition, anti-TNF therapies has been associated with a more severe course of HZ among patients with rheumatic diseases; those receiving anti-TNF therapies were 9 times more likely than those not to be hospitalized for HZ [9]. This evidence concerns the gene TNF and rheumatic disorder.